|
|
E B Lankford, N D Epstein, L Fananapazir, H L Sweeney
J Clin Invest. 1995;
95(3):1409
doi:10.1172/JCI117795
Abstract |
Full text
| PDF

M
issense mutations in the beta-myosin heavy chain (beta-MHC) gene cause hypertrophic cardiomyopathy (HCM). As normal and mutant beta-MHCs are expressed in slow-twitch skeletal muscle of HCM patients, we compared the contractile properties of single slow-twitch muscle fibers from patients with three distinct beta-MHC gene mutations and normal controls. Fibers with the 741Gly-->Arg mutation (near the binding site of essential light chain) demonstrated decreased maximum velocity of shortening (39% of normal) and decreased isometric force generation (42% of normal). Fibers with the 403Arg-->Gln mutation (at the actin interface of myosin) showed lowered force/stiffness ratio (56% of normal) and depressed velocity of shortening (50% of normal). Both the 741Gly-->Arg and 403Arg-->Gln mutation-containing fibers displayed abnormal force-velocity relationships and reduced power output. Fibers with the 256Gly-->Glu mutation (end of ATP-binding pocket) had contractile properties that were indistinguishable from normal. Thus there is variability in the nature and extent of functional impairments in skeletal fibers containing different beta-MHC gene mutations, which may correlate with the severity and penetrance of the disease that results from each mutation. These functional alterations likely constitute the primary stimulus for the cardiac hypertrophy that is characteristic of this disease.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(37)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
Richard L. Moss, Scott H. Buck
|
Comprehensive Physiology
|
2011 |
Comprehensive Physiology
Jeffery W. Walker
|
Comprehensive Physiology
|
2011 |
Structural Basis for Myopathic Defects Engendered by Alterations in the Myosin Rod
Anthony Cammarato, Xiaochuan (Edward) Li, Mary C. Reedy, Chi F. Lee, William Lehman, Sanford I. Bernstein
|
Journal of Molecular Biology
|
2011 |
Mechanical and Energetic Consequences of HCM-Causing Mutations
Cecilia Ferrantini, Alexandra Belus, Nicoletta Piroddi, Beatrice Scellini, Chiara Tesi, Corrado Poggesi
|
J. of Cardiovasc. Trans. Res.
|
2009 |
Protein Science Encyclopedia
John P. Konhilas, Leslie A. Leinwand
|
Protein Science Encyclopedia
|
2008 |
Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease
Philippe Charron, Michel Komajda
|
Expert Rev Mol Diagn
|
2006 |
The Genetic Bases of Cardiomyopathies
Pascale Richard, Eric Villard, Philippe Charron, Richard Isnard
|
Journal of the American College of Cardiology
|
2006 |
Clinical Characteristics of Heart Disease Patients With a Good Prognosis in Spite of Markedly Increased Plasma Levels of Type-B Natriuretic Peptide (BNP)
Ichiro Takeuchi, Takayuki Inomata, Mototsugu Nishii, Toshimi Koitabashi, Hironari Nakano, Hisahito Shinagawa, Hitoshi Takehana, Tohru Izumi
|
Circ J
|
2005 |
Hypertrophic cardiomyopathy: from gene defect to clinical disease
Man-Wei CHUNG, Tatiana TSOUTSMAN, Christopher SEMSARIAN
|
Cell Res
|
2003 |
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion
Houman Ashrafian, Charles Redwood, Edward Blair, Hugh Watkins
|
Trends in Genetics
|
2003 |
|